News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 205662

Wednesday, 02/11/2015 10:53:40 AM

Wednesday, February 11, 2015 10:53:40 AM

Post# of 347009

Plaintiffs in the Class Action: James T. Fahey (Highest Financial Stake)

The plaintiffs are:

(1) James T. Fahey
(2) Marshall Lee
(3) Jason Ebach and Mary Legnetti (“Ebach & Legnetti”)
(4) Allan L. Tereshko, Edward Buzz Bradley, and Edward Arduino (“Tereshko Investors Group”).



ok, now this gets even more interesting, because it seems there is a "John Fahey" and we all honestly don't believe that James T Fahey just decided to wake up one day and start buying a $hit load of PPHM for no apparent reason at all, just like many sides show up on here daily for months and years for no apparent reason

--------------

Robert Peter Gale, Hammersmith and Celgene, USA
The Diversity of Myeloid Cell Populations Driving Carcinogenesis

Amy-Jo Casbon, University of California, San Francisco, USA
Short Talk: Tumors Reprogram Early Myeloid Differentiation in the Bone Marrow to Generate Immunosuppressive Neutrophils

...
..
http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1314

-------------

Robert Peter Gale:

Gale received his A.B. degree with honors in biology and chemistry from Hobart College in 1966 and his M.D. degree from the State University of New York at Buffalo in 1970 (with Evan Caukins, Robin Bannerman and John Edwards). His postgraduate medical training (internal medicine, hematology and oncology) was at the University of California, Los Angeles (UCLA) from 1970–1973. In 1976 he received a Ph.D. in microbiology and immunology from the University of California at Los Angeles (UCLA) following doctoral work focusing on cancer immunology (with John Fahey). His postdoctoral studies at UCLA were funded by the U.S. National Institutes of Health (NIH) and the Leukemia Society of America, where he was the Bogart Fellow and Scholar.

Gale has published over 800 scientific articles and more than 20 books, mostly on leukemia (biology and treatment), transplantation (biology, immunology and treatment), cancer immunology and radiation (biological effects and accident response).

Gale lives in Los Angeles, New York and Big Sky, MT with his wife Laura.

http://en.wikipedia.org/wiki/Robert_Peter_Gale

---------------------

John Fahey MD

John L. Fahey is an immunologist, clinical researcher and educator who joined the UCLA School of Medicine faculty in 1971 as professor and chair (1971-1981) of the Department of Microbiology and Immunology and a joint appointment in the Department of Medicine. He was a major participant (with 4 other faculty) in the three original UCLA grant applications to the National Cancer Institute, NIH for Planning, for Comprehensive designation and for Construction (1/2 of Factor Building) of the Comprehensive Cancer Center at UCLA (1971-1981). He was Principal Investigator (with 10 associated faculty) for the Center for Interdisciplinary Research in Immunology and Disease, CIRID at UCLA, (1978-1998). John Fahey was PI on NIH Program Project grant on Immune Functions and Cancer (1972-1982). Also he originated two NIH Training Grants at UCLA: Clinical and Fundamental Immunology NIAID and Tumor Immunology NCI (1975). They have continued for more than 30 years under new leadership. Dr. Fahey was founding President of the Clinical Immunology Society (1986) and head of Clinical Immunology Section of the International Union of Immunological Societies (1992-1998). He was a designated Advisor for Immunology to the World Health Organization (1964-1994). He served on NIH Study Sections (1970-1976) and was Member, Council of the NIAID (1979-1985). He was a Member, US-Japan Cooperative Program on AIDS (1991-1995), Consultant to WHO and Faculty for WHO Centers for Immunology Research and Education in Eastern Europe, Africa and Southeast Asia (1964-1974). He has mentored more than 70 US and International postdoctoral scientists with MD or PhD qualifications for careers in biomedical research.

...
...
.

https://people.healthsciences.ucla.edu/institution/personnel?personnel_id=45630

-------------------

Now could the late John Fahey and James T Fahey be of relation?

If so.... I'm sure Peregrine legal is already aware and gives more pieces of the puzzle and other players to be aware of. Any and all names in this post may not mean a thing and any and all names of affiliations (that are not in this post) may not mean a thing either.... or it does and I'd say Peregrine has a few things they are holding back and saving for any possible trial where there is "NO LIMITS" for "constructive fraud"


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y